Search results for " LAB"

showing 10 items of 2393 documents

Voriconazole inhibits biofilm formation in different species of the genus Candida

2012

To determine the ability of voriconazole to inhibit the formation of biofilms.A total of 38 blood isolates of Candida spp. (8 Candida albicans, 10 Candida tropicalis, 10 Candida glabrata, 7 Candida parapsilosis sensu stricto and 3 Candida orthopsilosis) and C. albicans ATCC 90028 and ATCC 64548 were assessed. Biofilm formation was quantified using XTT reduction assays. The inhibition of biofilm formation was determined (i) in the presence of 0.06 and 0.25 mg/L voriconazole, and (ii) on surfaces previously coated with 0.06, 0.25, 1, 4 and 16 mg/L voriconazole.Voriconazole reduced biofilm formation under both conditions, the extent depending on the species, isolate and drug concentration. In …

Microbiology (medical)Antifungal AgentseducationTetrazolium SaltsBiologyCandida parapsilosisGenus CandidaMicrobiologymedicineHumansPharmacology (medical)Candida albicansSensu strictoCandidaPharmacologyVoriconazoleStaining and LabelingCandidiasisBiofilmTriazolesbiochemical phenomena metabolism and nutritionbiology.organism_classificationCorpus albicansPyrimidinesInfectious DiseasesBiofilmsCandida sppVoriconazolemedicine.drugJournal of Antimicrobial Chemotherapy
researchProduct

Epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole for six Candida species as determined by the colorimetric…

2013

ABSTRACT In the absence of clinical breakpoints (CBP), epidemiological cutoff values (ECVs) are useful to separate wild-type (WT) isolates (without mechanisms of resistance) from non-WT isolates (those that can harbor some resistance mechanisms), which is the goal of susceptibility tests. Sensititre YeastOne (SYO) is a widely used method to determine susceptibility of Candida spp. to antifungal agents. The CLSI CBP have been established, but not for the SYO method. The ECVs for four azoles, obtained using MIC distributions determined by the SYO method, were calculated via five methods (three statistical methods and based on the MIC 50 and modal MIC). Respectively, the median ECVs (in mg/lit…

Microbiology (medical)AzolesPosaconazolemedicine.medical_specialtyAntifungal AgentsItraconazoleMycologyMicrobial Sensitivity TestsBiologyMicrobiology:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]EpidemiologymedicineHumansCutoffCandida albicansPruebas de sensibilidad microbianaCandidaVoriconazoleCandidiasisLiter:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 1-Ring::Azoles [Medical Subject Headings]:Diseases::Bacterial Infections and Mycoses::Mycoses::Candidiasis [Medical Subject Headings]biology.organism_classification:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antifungal Agents [Medical Subject Headings]:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Microbiological Techniques::Microbial Sensitivity Tests [Medical Subject Headings]:Organisms::Eukaryota::Fungi::Mitosporic Fungi::Candida [Medical Subject Headings]AntifúngicosFluconazolemedicine.drug
researchProduct

Dot-immunobinding assay with the globular domain of collagen type IV for antiglomerular basement membrane antibodies

1988

A dot-immunobinding assay for the detection of antiglomerular basement membrane antibodies has been developed. The globular domain NC1 of basement membrane collagen type IV was used as antigen. The assay proved to be specific, sensitive, and reproducible. Circulating antibodies in each of 12 sera from patients with florid Goodpasture's syndrome could be demonstrated, whereas sera from patients with Goodpasture's syndrome in clinical remission and various control sera showed no reactivity. The advantages of the dot-blot assay are: the usage of the purified Goodpasature target antigen NCI reduces unspecific binding of IgG; only minimal amounts of antigen are required to give a positive signal…

Microbiology (medical)Basement membraneCollagen typebiologyChemistryBiochemistry (medical)Clinical BiochemistryPublic Health Environmental and Occupational HealthCirculating antibodiesHematologyVirologyMolecular biologyMedical Laboratory Technologychemistry.chemical_compoundmedicine.anatomical_structureAntigenmedicineGoodpasture's syndromebiology.proteinImmunology and AllergyAntibodyNitrocelluloseTarget antigenJournal of Clinical Laboratory Analysis
researchProduct

Relationship between the target antigen of liver-kidney microsomal (LKM) autoantibodies and rat isoenzymes of cytochrome P-450

1988

Chronic active hepatitis (CAH) is a clinical syndrome of different etiologies. Liver-kidney microsomal (LKM) autoantibodies characterize a subgroup of HBsAg negative CAH, which is considered to be an autoimmune liver disease. By immunoblotting analysis (IB) LKM positive sera have been shown to react strongly with a poly-peptide band at 50 kD. Therefore we investigated various rat microsomal enzymes with a molecular weight around 50 kD as potential candidate target antigens. These included epoxide hydrolase, cytochrome P-450 reductase, and phenobarbital-inducible isoenzymes of cytochrome P-450 (PB1, PB2, PB3a, PB3b). By radioimmunoassay (RIA) and IB LKM positive sera were shown to react with…

Microbiology (medical)Cytochromebiologymedicine.diagnostic_testBiochemistry (medical)Clinical BiochemistryPublic Health Environmental and Occupational HealthAutoantibodyHematologyReductaseImmunofluorescenceMolecular biologyEpitopeMedical Laboratory TechnologyAntigenBiochemistrybiology.proteinmedicineMicrosomeImmunology and AllergyEpoxide hydrolaseJournal of Clinical Laboratory Analysis
researchProduct

Leucine aminopeptidase is an immunodominant antigen of Fasciola hepatica excretory and secretory products in human infections.

2007

ABSTRACT The liver fluke Fasciola hepatica parasitizes humans and ruminant livestock worldwide, and it is now being considered a reemerging zoonotic disease, especially in areas in which it is endemic, such as South America. This study investigates the immune response to excretory and secretory products produced by F. hepatica in a group of patients from the Peruvian Altiplano, where the disease is highly endemic. Using a proteomic approach and immunoblotting techniques, we have identified the enzymes leucine aminopeptidase (LAP) and phosphoenolpyruvate carboxykinase as immunodominant antigens recognized by sera from fasciolosis patients. An indirect enzyme-linked immunosorbent assay using …

Microbiology (medical)FascioliasisAdolescentClinical BiochemistryImmunologyBlotting WesternMolecular Sequence DataSheep DiseasesEnzyme-Linked Immunosorbent AssayAminopeptidasePolymerase Chain ReactionLeucyl AminopeptidaseImmune systemAntigenHepaticaparasitic diseasesmedicineImmunology and AllergyFasciola hepaticaAnimalsHumansElectrophoresis Gel Two-DimensionalFasciolosisChildDNA PrimersSheepbiologyBase SequenceImmunodominant EpitopesClinical and Diagnostic Laboratory ImmunologyLiver flukeFasciola hepaticabiology.organism_classificationmedicine.diseaseVirologyExcretory systemAntigens HelminthChild PreschoolClinical and vaccine immunology : CVI
researchProduct

Methodology and significance of the detection of liver-kidney-microsomal (lkm) autoantibodies in autoimmune-type chronic active hepatitis

1987

Liver-kidney-microsomal (LKM) autoantibodies are diagnostic markers for a subgroup of HBsAg-negative chronic active hepatitis, presumably owing to autoimmunity. They were originally detected by indirect immunofluorescence and can now be evaluated by radioimmunoassay, enzyme-linked immunosorbent assay, and immunoblotting. In immunoblotting LKM-positive sera react strongly with a 50-kilodalton (KD) polypeptide band of microsomes. In immunoelectron microscopy, LKM-positive sera show a binding with membranes of the endoplasmic reticulum. The LKM antigen was further identified on various isoenzymes of cytochrome P-450. Immunofluorescence is still the method of choice for screening sera routinely…

Microbiology (medical)HepatitisPathologymedicine.medical_specialtyCirrhosismedicine.diagnostic_testImmunoelectron microscopyBiochemistry (medical)Clinical BiochemistryPublic Health Environmental and Occupational HealthAutoantibodyRadioimmunoassayHematologyBiologymedicine.diseasemedicine.disease_causeImmunofluorescenceAutoimmunityMedical Laboratory TechnologyAntigenImmunologymedicineImmunology and AllergyJournal of Clinical Laboratory Analysis
researchProduct

Significant autoimmune markers of autoimmune liver disorders: Current status

1987

Microbiology (medical)Hepatitisbusiness.industryBiochemistry (medical)Clinical BiochemistryPublic Health Environmental and Occupational HealthAutoantibodyHematologymedicine.disease_causemedicine.diseaseAutoimmunityMedical Laboratory TechnologyPrimary biliary cirrhosisImmunologymedicineImmunology and AllergybusinessJournal of Clinical Laboratory Analysis
researchProduct

Evaluation of the Architect Epstein-Barr Virus (EBV) Viral Capsid Antigen (VCA) IgG, VCA IgM, and EBV Nuclear Antigen 1 IgG Chemiluminescent Immunoas…

2014

ABSTRACTCommercial immunoassays for detecting IgG and IgM antibodies against Epstein-Barr virus (EBV), viral capsid antigens (VCA), and IgGs toward EBV nuclear antigen-1 (EBNA-1) are routinely used in combination to categorize EBV infection status. In this study, we evaluated the performances of the Architect EBV VCA IgG, VCA IgM, and EBNA-1 IgG chemiluminescent microparticle assays (CMIAs) in EBV serological analyses using indirect immunofluorescence assays and anticomplement immunofluorescence assays as the reference methods for VCA IgG, VCA IgM, and EBNA-1 IgG antibody detection, respectively. A total of 365 serum samples representing different EBV serological profiles were included in t…

Microbiology (medical)MaleEpstein-Barr Virus InfectionsHerpesvirus 4 HumanClinical BiochemistryImmunologyFluorescent Antibody Techniquemedicine.disease_causeImmunofluorescenceAntibodies ViralSensitivity and SpecificityImmunoglobulin GSerologyAntigenhemic and lymphatic diseasesDiagnostic Laboratory Immunologyotorhinolaryngologic diseasesImmunology and AllergyMedicineHumansChildAntigens ViralImmunoassaymedicine.diagnostic_testbiologybusiness.industryDiagnostic Tests RoutineInfantVirologyEpstein–Barr virusstomatognathic diseasesEpstein-Barr Virus Nuclear AntigensImmunoglobulin MImmunoglobulin MImmunoassayChild PreschoolImmunoglobulin GImmunologyLuminescent Measurementsbiology.proteinCapsid ProteinsFemaleAntibodybusiness
researchProduct

Optimization of the preanalytical steps of matrix-assisted laser desorption ionization-time of flight mass spectrometry identification provides a fle…

2012

ABSTRACT We report here that modifications of the preanalytical steps of matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) identification of yeasts, with regard to the original protocol provided by the manufacturers, appear to be efficient for the reliable routine identification of clinical yeast isolates in medical laboratories. Indeed, when one colony was sampled instead of five and the protein extraction protocol was modified, the performance of MALDI-TOF MS was superior to that of the API ID 32C method (discrepancies were confirmed by using molecular identification), allowing the correct identification of 94% of the 335 clinical isolates prospec…

Microbiology (medical)Microbiological TechniquesTime Factorsmedical laboratories[SDV]Life Sciences [q-bio]clinical yeast isolatesMatrix assisted laser desorption ionization time of flightMycologyMass spectrometrySpecimen Handlingflight mass spectrometry03 medical and health sciencesYeastsHumansionization-time030304 developmental biologyMolecular identification0303 health sciencesChromatography030306 microbiologyChemistryYeastCulture MediaIdentification (information)Mycosesmatrix-assisted laserSpectrometry Mass Matrix-Assisted Laser Desorption-Ionization[SDE]Environmental SciencesidentificationJournal of clinical microbiology
researchProduct

Ethidium bromide: a fast fluorescent staining procedure for the detection of symbiotic partnership of flagellates and prokaryotes

1999

The hindgut of 'lower' termites harbors a dense population of flagellates and bacteria. The flagellates possess ecto- and endosymbiotic prokaryotes. Most of them are hardly visible in the phase contrast microscope. Staining with the DNA-intercalating agent ethidium bromide visualizes the nuclei of the flagellates as well as the ecto- and endosymbiotic bacteria as red objects. Furthermore, it is possible to distinguish between endosymbiotic methanogens and other bacteria. Following UV excitation, the blue-green autofluorescence of the methanogenic bacteria eclipses the red fluorescence light of the intercalated ethidium bromide. The dye facilitates the observation of symbiotic bacteria and h…

Microbiology (medical)MicroorganismPopulationIsopteraMicrobiologyFluorescenceMicrobiologychemistry.chemical_compoundMastotermes darwiniensisEthidiumAnimalsSymbiosiseducationMolecular Biologyeducation.field_of_studyBacteriaStaining and Labelingbiologybiology.organism_classificationStainingTrichomonadidaAutofluorescencechemistryBiochemistryEthidium bromideDigestive SystemBacteriaSymbiotic bacteriaJournal of Microbiological Methods
researchProduct